Long-term amygdalohippocampal stimulation for refractory temporal lobe epilepsy

被引:223
作者
Vonck, K
Boon, P
Achten, E
De Reuck, J
Caemaert, J
机构
[1] State Univ Ghent Hosp, Dept Neurol, Reference Ctr Refractory Epilepsy, B-9000 Ghent, Belgium
[2] State Univ Ghent Hosp, Dept Neuroradiol, Reference Ctr Refractory Epilepsy, B-9000 Ghent, Belgium
[3] State Univ Ghent Hosp, Dept Neurosurg, Reference Ctr Refractory Epilepsy, B-9000 Ghent, Belgium
关键词
D O I
10.1002/ana.10323
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Short-term deep brain stimulation (DBS) recently has been shown to be efficacious in refractory temporal lobe epilepsy. We (1) evaluated long-term DBS in medial temporal lobe structures in patients with normal magnetic resonance imaging (MRI) findings and (2) investigated the use of chronic DBS electrodes for the localization of the ictal onset zone before DBS. In three patients with complex partial seizures (CPSs), DBS electrodes were implanted in the amygdalohippocampal region to identify and subsequently stimulate the ictal onset zone. CPSs were compared before and after chronic DBS. Side effects were carefully monitored. DBS electrodes yielded high-quality electroencephalogram recordings showing unilateral seizure onset in medial temporal lobe structures. For all patients, unilateral amygdalohippocampal stimulation was performed. After a mean follow-up of 5 months (range, 3-6 months), all patients had a greater than 50% reduction in seizure frequency. In two patients, antiepileptic drugs could be tapered. None of the patients reported side effects. This open study demonstrates the feasibility of consecutive electroencephalographic recordings and DBS in medial temporal lobe structures using DBS electrodes. These results prompt further studies in a larger patient population to establish the efficacy and safety of chronic DBS as an alternative treatment for refractory temporal lobe epilepsy.
引用
收藏
页码:556 / 565
页数:10
相关论文
共 29 条
[1]  
Benabid AL, 2001, J Neurol, V248, pIII37, DOI [10.1007/PL00007825, DOI 10.1007/PL00007825]
[2]   Proof of principle trials: EEG surrogate endpoints [J].
Binnie, C .
EPILEPSY RESEARCH, 2001, 45 (1-3) :7-11
[3]  
Boon P, 1996, ACTA NEUROL BELG, V96, P6
[4]  
Boon P., 1996, EPILEPSIA, V37, P146
[5]   Determinants of seizure threshold in ECT: Benzodiazepine use, anesthetic dosage, and other factors [J].
Boylan, LS ;
Haskett, RF ;
Mulsant, BH ;
Greenberg, RM ;
Prudic, J ;
Spicknall, K ;
Lisanby, SH ;
Sackeim, HA .
JOURNAL OF ECT, 2000, 16 (01) :3-18
[6]  
Bruder N, 2001, ANN FR ANESTH, V20, P171
[7]   Effects of therapeutic stimulation of nucleus caudatus on epileptic electrical activity of brain in patients with intractable epilepsy [J].
Chkhenkeli, SA ;
Chkhenkeli, IS .
STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 1997, 69 (1-4) :221-224
[8]  
Engel Jerome Jr., 1993, P609
[9]  
FEINSTEIN B, 1989, FUNCT NEUROSURG, V43, P906
[10]   PLACEBO-CONTROLLED PILOT-STUDY OF CENTROMEDIAN THALAMIC-STIMULATION IN TREATMENT OF INTRACTABLE SEIZURES [J].
FISHER, RS ;
UEMATSU, S ;
KRAUSS, GL ;
CYSYK, BJ ;
MCPHERSON, R ;
LESER, RP ;
GORDON, B ;
SCHWERDT, P ;
RISE, M .
EPILEPSIA, 1992, 33 (05) :841-851